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ABSTRACT
Intron removal during pre-messenger RNA (pre-
mRNA) splicing involves arrangement of snRNAs
into conformations that promote the two catalytic
steps. The Prp19 complex [nineteen complex
(NTC)] can specify U5 and U6 snRNA interactions
with pre-mRNA during spliceosome activation.
A candidate for linking the NTC to the snRNAs is
the NTC protein Cwc2, which contains motifs
known to bind RNA, a zinc finger and RNA recogni-
tion motif (RRM). In yeast cells mutation of either
the zinc finger or RRM destabilize Cwc2 and are
lethal. Yeast cells depleted of Cwc2 accumulate
pre-mRNA and display reduced levels of U1, U4,
U5 and U6 snRNAs. Cwc2 depletion also reduces
U4/U6 snRNA complex levels, as found with deple-
tion of other NTC proteins, but without increase in
free U4. Purified Cwc2 displays general RNA binding
properties and can bind both snRNAs and pre-
mRNA in vitro. A Cwc2 RRM fragment alone can
bind RNA but with reduced efficiency. Under spli-
cing conditions Cwc2 can associate with U2, U5
and U6 snRNAs, but can only be crosslinked directly
to the U6 snRNA. Cwc2 associates with U6 both
before and after the first step of splicing. We pro-
pose that Cwc2 links the NTC to the spliceosome
during pre-mRNA splicing through the U6 snRNA.
INTRODUCTION
The removal of intron regions from pre-messenger RNA
(pre-mRNA) by the process of pre-mRNA splicing is an
essential step during gene expression. Intron regions must
be removed accurately and eﬃciently to produce mRNA
that retains the original protein coding potential of the
gene. Pre-mRNA splicing is carried out by a large RNA/
protein complex called the spliceosome. The spliceosome
contains ﬁve small nuclear ribonucleoprotein particles
(snRNPs) that are RNA/protein complexes named after
the single small nuclear RNA (U1, U2, U4, U5 or U6
snRNA) that each contains. In addition to the snRNPs,
there are also numerous non-snRNP protein factors that
associate with the spliceosome that are essential for pre-
mRNA splicing (1).
A number of interactions take place to form the active
spliceosome which is competent for intron removal (2,3).
First, the U1 snRNP interacts with the 50-splice site
region. Next, the U2 snRNP interacts with the branch-
point sequence. Following interaction of the U1 and U2
snRNPs with the pre-mRNA, the U4/U6.U5 tri-snRNP
interacts with the pre-mRNA and the bound U1 and U2
snRNPs. After joining of the tri-snRNP, structural rear-
rangements follow that destabilize the association
of the U1 and U4 snRNPs with the spliceosome. These
structural rearrangements include changes in RNA/RNA
interactions that set up the spliceosome for catalysis.
Speciﬁcally the U1 snRNA base pairing at the 50-splice
site is replaced by a U5 snRNA interaction with the
50-exon and a U6 snRNA interaction with the 50-end of
the intron. In addition, U4/U6 base pairing is replaced by
U6 base pairing with the U2 snRNA. These RNA/RNA
interactions form the active site of the spliceosome for the
ﬁrst step of splicing. The second step of splicing occurs
rapidly after the ﬁrst step producing the mRNA molecule.
The spliceosome then disassembles and the snRNPs are
recycled for use in another round of splicing.
Protein factors have been implicated in mediating the
RNA rearrangements required for spliceosome activation.
In yeast, Prp28 is involved in the displacement of U1 from
the 50-splice site (4). Brr2 catalyzes U4/U6 snRNA
unwinding during spliceosome activation (5) and U2/U6
unwinding after splicing, with Brr2 activity being regu-
lated by Snu114 (6). Following U1 and U4 destabilization
from the spliceosome, a protein complex associated with
the Prp19 protein termed the NTC (nineteen complex) is
required for the stable association of the U5 and U6
snRNAs with the 50-splice site region (7,8). The NTC spe-
ciﬁes and stabilizes dynamic interactions of U5 and U6
with the 50-splice site (7). The NTC is also required for
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allowing the 30-end to contact the intron (7). The NTC
then remains associated with the spliceosome during the
two catalytic steps of splicing. The NTC consists of at
least 10 protein components in the yeast Saccharomyces
cerevisiae (8,9). In addition to their role in activation of
the spliceosome, proteins of the NTC have also been
implicated in 30-splice site surveillance as a number of
NTC proteins interact with second step splicing factors
(9–12) and the human NTC complex is required for the
second step of splicing (13). The NTC has recently been
found to have an indirect role in spliceosome recycling by
inﬂuencing U4/U6 stability/biogenesis (14).
The function of the NTC during activation of the
spliceosome undoubtedly involves interactions with the
snRNAs, but no NTC component has been found to
bind RNA. Cwc2/Ntc40 is the only protein of the NTC
complex that contains known motifs for RNA binding,
namely a zinc ﬁnger and an RNA recognition motif
(RRM) (9). Cwc2 is required for splicing and has been
demonstrated to interact with Prp19 by far western,
in vitro binding and two-hybrid analysis (9,15). Two-
hybrid analysis has further deﬁned the Cwc2/Prp19
interaction domains to the C-terminal portion of Cwc2
(downstream from the zinc ﬁnger and RRM) and the
C-terminal two-thirds of Prp19 including the WD40
domain (9). Cwc2 also interacts with Ntc30/Isy1, another
protein of the NTC (9). To date, there is no information
regarding whether Cwc2 interacts with the RNA compo-
nents of the spliceosome.
To further deﬁne the function of the NTC in the acti-
vation of the spliceosome, we set out to investigate if Cwc2
interacts with the RNAs of the spliceosome. Depletion of
Cwc2 in vivo results in the destablization of U1, U4, U5
and U6 snRNA, leading to reduced levels of the U4/U6
complex. Puriﬁed Cwc2 can bind directly to all ﬁve spli-
ceosomal snRNAs and three diﬀerent pre-mRNAs
in vitro. In splicing extracts Cwc2 is not snRNP associated,
but during splicing Cwc2 interacts with spliceosomes con-
taining the U2, U5 and U6 snRNAs. Mutation of Cwc2
revealed that the zinc ﬁnger motif and the RRM are essen-
tial for Cwc2 stability. A puriﬁed RRM fragment of
Cwc2, lacking the zinc ﬁnger, binds U1, U2, U4 and U6
snRNAs in vitro, but not U5 snRNA. We propose that
Cwc2 displays general RNA binding properties that are
mediated at least in part by the RRM and possibly the
zinc ﬁnger motif. Within splicing extracts Cwc2 crosslinks
directly to the U6 snRNA and we suggest that the general
RNA binding properties of Cwc2 may be regulated by
other NTC/spliceosomal components. Overall, we pro-
pose that Cwc2 provides the link between the NTC and
the spliceosome through the U6 snRNA.
MATERIALS AND METHODS
Plasmid construction and mutagenesis
The CWC2 (YDL209C) gene was cloned by PCR ampli-
ﬁcation of S. cerevisiae genomic DNA (Promega) with
primers 209FG-50-GGTCTAGATTTCTAATATGGTT
AAGAAGCG and 209BG-50-GGGGATCCTTGCAGG
TATCTACTACAAAG containing restriction sites for
XbaI and BamHI, respectively. The PCR product was
digested with XbaI and BamHI, then ligated into
pRS416 (16) digested with the same enzymes to produce
pRS416-Cwc2. The identity of the insert was conﬁrmed
by sequencing. The XbaI/BamHI fragment containing
the CWC2 gene was then excised from pRS416-Cwc2
and ligated into pRS413 to produce pRS413-Cwc2. A
3FLAG tagged version of Cwc2 in pRS413 was produced
by overlap PCR of pRS413-Cwc2 with primer pairs
209FG/Cwc2FLAGB (50-CTTTGTCGTCATCGTCCTT
GTAATCTTTGTCATCATCGTCTTTGTAATCCTCA
TCAGAGGAGAGGT) and 209BG/Cwc2FLAGF (50-TT
ACAAGGACGATGACGACAAAGATTACAAGGAT
GATGATGATAAGTAGAGAAGAAAATCGTTTCC)
then ligation into pRS413 to produce pRS413-
Cwc2-3FLAG. Mutagenesis of pRS413-Cwc2-3FLAG
was carried out according to the method of Kunkel (17)
with primers: C73Y-50-TGCAAAAAATAGATAGAA
GAACAACTG; T136V-50-ACCTACATACAAAACCT
TGTTTTTCTT; Y34A-50-CCCTTGGGACCATTTATT
AGCCCATATATTAAACTGCAATCC; W37A-50-CGC
AAACCCTTGGGAAGCTTTATTATACCATATATT
AAACG; C73Y-50-TGCAAAAAATAGATAGAAGAA
CAACTG; C86H-50-GGTATATGATGCAGATATTCA
TGTTTAGGGCCAAGGCAAC; Y138A-50-AATACCA
CCTACCGCCAATGTCTTGTT; F183D-50-GCATTA
GCTTGATATTTAAACTTCACATCTCCACAGTTTT
TGCTCTCAAC; F186D-50-CAAATTCTGCATTAGC
TTGATATTTATCCTTCACAAATCCACAGTTTTTG.
The ACT1 pre-mRNA was excised from plasmid p283
(18) with SacI and XbaI and inserted into SacI/XbaI
digested pBluescript II KS+ (Stratagene) in the T7 orien-
tation to produce plasmid pBS-Actin. Mutagenesis of
pBS-Actin to produce pBS-ActinACAC for production
of ACAC pre-mRNA was carried out according to the
method of Kunkel (17) with primer ActACAC-50-GCTA
TATTATATGTTTACACGTTGCTGCTTTGG. All
mutagenesis was conﬁrmed by sequencing.
Yeast manipulation
For analysis of CWC2 mutations, the diploid strain
Y23907 (BY4743; Mat a/; his3D1/his3D1; leu2D0/
leu2D0; lys2D0/LYS2; MET15/met15D0; ura3D0/ura3D0;
YDL209c::kanMX4/YDL209c) was obtained from
EUROSCARF and was transformed with pRS416-Cwc2
by lithium acetate transformation (19). Viable
G418-resistant and Ura+ transformants were sporulated
and tetrads dissected. The haploid progeny were analyzed
to identify the strain YCWC2KO (BY4743; Mat a; his3D1;
leu2D0; lys2D0; MET15; ura3D0; YDL209c::kanMX4;
pRS416-Cwc2). This strain was transformed with
pRS413-Cwc2-3FLAG plasmids containing diﬀerent
CWC2 mutations and cells were tested for viability by
plasmid shuﬄe on 5-ﬂuoro-orotic acid (5-FOA) (20). A
yeast strain with the CWC2 gene under control of the
GAL1 promoter was constructed by PCR of plasmid
pFA6a-kanMX6-PGAL1 (21) with primers 209GALF-
50-ATTATGTATTGAAGGCTGGATCATAATAAAG
ACTACTGGCGATGGGAATTCGAGCTCGTTTAAA
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GCGGATTTATCCCTCCAAGATGTCATTTTGAGA
TCCGGGTTTT. The resulting PCR product was trans-
formed into yeast strain BY4743 (Mat a/; his3D1/his3D1;
leu2D0/leu2D0; lys2D0/LYS2; MET15/met15D0; ura3D0/
ura3D0) and G418-resistant colonies were selected.
Integration of the GAL1 promoter was conﬁrmed by
PCR and these strains were sporulated and tetrads dis-
sected. Haploid progeny were analyzed to identify the
strain YGALCWC2 (BY4743; Mat a; his3D1; leu2D0;
lys2D0; MET15; ura3D0; kanMX6:PGAL1-CWC2). TAP
tagged CWC2, PRP21 and PRP11 were produced by
PCR of plasmid pYM13 (22) with primers Cwc2TAPF-
50-GGTAAGCTTGGTGGTCCCTTGCTCGATTACCT
CTCCTCTGATGAGGATCGTACGCTGCAGGTCGA
C and Cwc2TAPB-50-TGTTAATGGCAGATACTTAG
AATTTGGTGGAAACGATTTTCTTCTCTAATCGA
TGAATTCGAGCTCG, Prp21TAPF-50-CGTAAAATT
AGAGCTGTGGGAGAGACAAGGTTAAAGAAAAG
TAAAAAACGTACGCTGCAGGTCGAC and
Prp21TAPB-50-CATCAACCTTTACATACTTCTAGCT
AACTTTGATTTTCATGAGGCTTAATCGATGAAT
TCGAGCTCG or Prp11TAPF-50-TACGTTCAATTTTT
CTTTAAACAAGCCGAACAAGAACAAGCCGATG
TACGTACGCTGCAGGTCGAC and Prp11TAPB-50-A
GAGTTTTGTATGCCGATTATTAACGTTACCCAA
AAATAATACTGTCAATCGATGAATTCGAGCTCG.
The resulting PCR products were transformed into yeast
strain BJ2168 (Mat a; prc1-407; prb1-122; pep4-3; leu2;
trp1; ura3-52; gal2) and G418-resistant colonies were
selected. Integration of the TAP tag was conﬁrmed by
PCR and the strains called YCWC2TAP, YPRP21TAP
and YPRP11TAP. Growth curves in liquid culture were
obtained as previously described (23).
Analysis of Cwc2 expression
Yeast strain YCWC2KO was transformed with the CEN
HIS3 pRS413-Cwc2-3FLAG plasmid containing either
wild-type or mutant Cwc2-3FLAG. Overnight cultures
grown under selection for the CEN URA3 plasmid, con-
taining the wild-type CWC2 gene, and the CEN HIS3 plas-
mid were used to seed 25ml cultures at an OD600 of 0.5.
These were grown for 4h at 308C, harvested at 2000g for
5min, washed, repelleted and resuspendend in 200ml SDS
sample buﬀer (60mM Tris–HCl pH 6.8, 10% glycerol, 2%
SDS, 5% 2-mercaptoethanol, 0.5% Bromophenol blue).
Acid-washed glass beads (Sigma, 425–600m) were added
to the liquid level before addition of a further 200ml SDS
sample buﬀer. Samples were then boiled for 5min,
vortexed for 3min and 30ml was used for SDS–PAGE
and western blotting. Anti-FLAG M2 (Sigma) was used
at a concentration of 1:20000 and anti-Zwf1 (G6PDH,
Sigma) antibody at 1:50000.
Primer extension and immunoprecipitation
RNA isolation and primer extension to determine U3
snoRNA splicing and snRNA levels in the YGALCWC2
strain were as previously described (23) using
primers U3snoRNA-RT, U1H, U5RT, U2RT2, U6B or
U4S2. For immunoprecipitation of snRNAs from the
YCWC2TAP and YPRP21TAP strains, yeast whole-cell
extract was produced as described (24). Extract (50ml) was
either diluted with 350ml IPP150 (10mM Tris–HCl pH 8,
150mM NaCl, 0.5% Igepal-630) or used in a 125ml spli-
cing reaction for 30min at 238C, then diluted with 275ml
IPP150. Splicing reactions were carried out according to
published procedures (25) except that 4nM Ac/Cla or
ACAC pre-mRNA was utilized to accumulate spliceo-
somes. Extract diluted with IPP150 was mixed with 50ml
rabbit IgG agarose beads (Sigma) and incubated at 48C
for 45min. Beads were then washed four times with
IPP150, the last wash removed, then beads suspended in
splicing diluent (0.3M NaOAc pH 3, 1mM EDTA, 0.1%
SDS, 25mg/ml E.coli tRNA). The beads were phenol
extracted three times and RNA precipitated from the aque-
ous phase. Precipitated RNA and RNA isolated directly
from the extract were subjected to primer extension as
previously described (23) with primers U1RT136-50-GA
CCAAGGAGTTTGCATCAATGAC, U2RTAll-50-GCC
AAAAAATGTGTATTGT AAC, U4RTAll-50-GGTATT
CCAAAAATTCCCTACATAGTC, U5RT-50-AAAAAT
ATGGCAGG CCTACAGTAACGG and U6RTAll-50-T
CATCCTTATGCAGGG. Extension reactions were sepa-
rated on 40cm 6% acrylamide/7M urea gels.
Crosslinking
YCWC2TAP and YPRP11TAP whole-cell extract (100ml)
was used in 250ml splicing reactions for 30min at 238C.
Splicing reactions were carried out according to published
procedures (25) except that 4nM Ac/Cla or ACAC pre-
mRNA was utilized to accumulate spliceosomes.
Reactions were irradiated three times at 411mJ/cm
2 in a
Stratalinker (Stratagene model 2400) on ice before addi-
tion of 250ml2   binding buﬀer (20mM Tris–HCl pH 7.5,
1M NaCl, 1% SDS, 0.2mM EDTA). Streptavidin coated
Dynabeads (Dynal m270) were prepared by washing
200ml slurry three times with 400ml1   binding buﬀer,
incubation at room temperature for 15min with 1mM
biotinylated oligonucleotide complementary to U5, U2
or U6 (U5BioTEG 50-AAGTTCCAAAAAATATGGCA
AGC, U2BioTEG 50-TTGGGTGCCAAAAAATGTG,
U6BioTEG 50-AAAACGAAATAAATCTCTTTG) in
1  binding buﬀer and washing a further three times
with 400ml1   binding buﬀer. Beads were then added to
the crosslinked splicing reactions and incubated at 308C
for 1h, mixing once during this time. After washing three
times with 1ml 1  binding buﬀer proteins were eluted in
400ml elution buﬀer (10m Tris–HCl pH 7.5, 1mM EDTA)
with 4ml RNase cocktail (Ambion) at 378C for 30min.
Proteins were then precipitated by addition of 100ml
100% TCA, 0.4% sodium deoxycholate on ice for
20min and pelleted at 16 100g at 48C for 15min. Pellets
were washed with cold acetone and resuspended in SDS
sample buﬀer. Western blotting was then carried out using
anti-TAP antibody (Open Biosystems) at a dilution of
1:2000.
Analysis of the U4/U6 complex
The U4/U6 complex was analyzed by solution hybridiza-
tion (26). Brieﬂy, a 5ml overnight culture of the
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4 and 8h cultures in YPD and YPGal at an OD600 of
0.5 and 0.2, respectively. These were grown for 4 or 8h
to an OD600 between 1 and 2. Cells were then diluted with
25ml ice-cold water and pelleted at 2000g for 5min.
Pellets were resuspended in 1ml cold RNA buﬀer (0.5M
NaCl, 200mM Tris–HCl pH 7.5, 10mM EDTA), trans-
ferred to a 1.5ml tube and centrifuged at 4.5g for 5s.
Pellets were then resuspended in 300ml RNA buﬀer, vor-
texed with  200ml acid washed glass beads for 2min at
48C and centrifuged at 15600g for 1min. Each sample was
extracted twice with an equal volume of sodium acetate-
buﬀered phenol/chloroform/iso-amyl alcohol (25:24:1)
before ethanol precipitation. A total of 2.3mg of RNA
was annealed to 0.2 pmol 50 32P-labeled primer U6D:
50-AAAACGAAATAAATCTCTTTG or U4B: 50-AGG
TATTCCAAAAATTCCC in annealing buﬀer (150mM
NaCl, 50mM Tris–HCl pH 7.5, 1mM EDTA) at 378C
for 15min. Reactions were then electrophoresed on
15cm, 0.4mm thick, 9% nondenaturing polyacrylamide
gels(30:1acrylamide:bisacrylamide) at150Vfor4hat48C.
Expression and purification of recombinant Cwc2 and
Cwc2 RRM fragment
The Cwc2 open reading frame was PCR ampliﬁed
from pRS416-Cwc2 with primers 209PETF 50-CTA
GTACATATGACATCTTGGAGGGATAAATCCGCG
and 209PETB 50-CAGCTACTCGAGATCCTCATCAG
AGGAGAGGTAATCGAGC containing restriction
sites for NdeI and XhoI. The Cwc2 RRM fragment was
PCR ampliﬁed with primers Cwc2PET-Frag6 50-CATA
TGGGCGGGATCGGTTCATTTAGGAAG and
209PETB. The PCR products were digested with XhoI
then cloned into XhoI/EcoRV digested pBluescript II
KS+ to produce pBS-Cwc2 and pBS-Cwc2RRM, which
were then sequenced. The Cwc2 full-length and RRM
fragment open reading frame were excised from pBS-
Cwc2 and pBS-Cwc2RRM with NdeI and XhoI, then
cloned into similarly digested pET30b (Novagen) to pro-
duce pET30b-Cwc2 and pET30b-Cwc2RRM, respec-
tively. The plasmids were transformed into Escherichia
coli strain Rosetta 2 (DE3) (Novagen). C-terminally
6His-tagged Cwc2 and RRM fragments were expressed
in 500ml Overnight Express medium (Novagen) for 24h
at 198C and 378C, respectively. 6His-tagged Cwc2 and the
RRM fragment were puriﬁed according to a previously
published puriﬁcation protocol (23).
RNA transcription and electrophoretic mobility shift assay
The U1, U2, U3, U4, U5, U6, U14, ACT1, CYH2 and
RPS10B RNAs were transcribed from PCR-generated
template primed with UpG to allow end labeling
according to published procedures (23,27). All RNAs
were full length except for U2, which lacked  1kb of
yeast-speciﬁc sequence, and U3, which lacked stem loops
2, 3 and 4. The U6 snRNA 30-end contained a cyclic
phosphate produced by ribozyme cleavage (28). Plasmid
pBS-Actin was digested with EcoRV or ClaI for run-oﬀ
transcription of Actin or Actin Ac/Cla pre-mRNA,
respectively. Plasmid pBS-ActinACAC was digested with
EcoRV for run-oﬀ transcription of Actin ACAC
pre-mRNA. Electrophoretic mobility shift assay
(EMSA) reactions were performed with a range of protein
concentrations in 20mM HEPES–KOH pH 7.9, 300mM
NaCl, 10mM ZnCl2, 10% glycerol, 10mM DTT, 0.45mg/
ml E. coli tRNA and 0.8mg/ml BSA. 15000dpm of
end-labeled RNA was added and reactions were incubated
at room temperature for 10min before addition of 0.4
volume glycerol loading dye (0.05% bromophenol blue,
10% glycerol). Reactions were then resolved on 15cm,
native 5% acrylamide gels (37.5:1 acrylamide:bisacryla-
mide) in 1  Tris–borate buﬀer containing 6% glycerol
for 3.5h at 150V.
RESULTS
Cwc2 contains a zinc finger and a nonconsensus RRM
Analysis of the Cwc2 protein sequence reveals two speciﬁc
motifs that may be involved in nucleic acid and/or protein
interactions (Figure 1). The ﬁrst motif, amino acids 73–91,
is a CCCH zinc ﬁnger of the Cx7Cx5Cx3H type. The
second motif, amino acids 135–214, is an RRM. The
RRM contains a well-conserved RNP2 motif, however,
the RNP1 motif is less conserved compared with the con-
sensus for that motif (Figure 1B). The RNP1 of Cwc2 has
an extra amino acid separating the two aromatic residues
that are important for RNA binding. The RNP1 of Cwc2
also does not ﬁt the consensus for the U2AF homology
motif (UHM), a protein interaction variant of the RRM,
even though Cwc2 has a lower pI (7.97) characteristic of
other UHMs (29). Alignment of Cwc2 with its orthologs
in other organisms reveals that it has 54%, 43% and
40% amino acid identity with other fungal Cwc2 genes
from Kluyveromyces lactis, Aspergillus fumigatus and
Schizosaccharomyces pombe, respectively (Figure 1C).
The closest human ortholog is RBM22. However, amino
acid identity is only 27% with similarities between Cwc2
and RBM22 only in the central region containing the zinc
ﬁnger and RRM with the N- and C-terminus of Cwc2 and
RBM22 being quite divergent. RBM22 has recently been
found to be one of the core proteins of a puriﬁed human
spliceosomal C complex able to carry out the second step
of splicing (30). The presence of the zinc ﬁnger and RRM
indicates that these regions may be important for RNA
and/or protein binding of Cwc2.
Cwc2 is essential for splicing in vivo and for the levels of the
U1, U4, U5 and U6 snRNAs
Recent work has implicated the NTC in spliceosome recy-
cling and U4/U6 snRNP stability/biogenesis (14).
Speciﬁcally, when expression of essential NTC genes
PRP19, NTC90 or NTC77 are switched oﬀ there is an
accumulation of the free form of U4 snRNP (14). A
more detailed study of strains deleted for the nonessential
NTC25,o rNTC25 and NTC30 together, revealed a
decrease in levels of free U6 snRNA resulting in reduced
levels of the U4/U6 di-snRNP and increased levels of free
U4 snRNP (14). It was suggested that the deﬁciency
in U4/U6 stability/biogenesis resulted from inhibition of
spliceosome recycling and may be a general eﬀect of
4208 Nucleic Acids Research, 2009, Vol. 37,No. 13Figure 1. Domain structure and alignment of Cwc2. (A) Depiction of the protein motifs found in Cwc2. The location of the zinc ﬁnger and RRM
are shown. The region of Cwc2 (amino acids 228–339) found to interact with Prp19 by two-hybrid and pull-down analysis is also shown (9).
(B) Comparison of consensus RNP1 and RNP2 sequences with Cwc2 RNP1 and RNP2 sequences (X is for any amino acid). The aromatic residues,
which are important for RNA binding, are highlighted. (C) The amino acid sequence of Cwc2 from S. cerevisiae (Sc, NCBI-GI: 6319992) was aligned
with orthologs from K. lactis (Kl, NCBI-GI: 50305857), A. fumigatus (Af, NCBI-GI: 70998470), S. pombe (Sp, NCBI-GI: 19114249) and Homo
sapiens (Hs, NCBI-GI: 8922328). Orthologs were identiﬁed using KEGG and the alignment was made with ClustalW and Jalview.
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GAL1 regulated CWC2 gene to investigate the levels of
snRNAs and the U4/U6 snRNA complex when expres-
sion of CWC2 is turned oﬀ. Growth of the GAL1 regu-
lated CWC2 in glucose to shut oﬀ expression of CWC2
results in the inhibition of cell growth (Figure 2A).
Switching oﬀ the expression of CWC2 also results in the
accumulation of unspliced precursor RNA, typical of inhi-
bition of splicing (Figure 2B). Primer extension analysis of
total RNA isolated at 0, 4 and 8h following the switch to
glucose reveals that levels of U6 are decreased when
expression of CWC2 is turned oﬀ (Figure 2C), similar to
that described for other NTC proteins (14). Interestingly,
when expression of CWC2 is switched oﬀ, we also observe
a signiﬁcant decrease in levels of the U1 and U5 snRNAs
and a small decrease in U4 levels that has not been
observed for other NTC proteins (Figure 2C). Levels of
U2 snRNA do not decrease. In addition, native gel elec-
trophoresis revealed a dramatic decrease in the level of
base-paired U4/U6 as well as decreased levels of free U4
and U6 (Figure 2D). This agrees with the primer extension
results, which demonstrate a reduction in total levels of
U4 rather than just base-paired U4. Surprisingly, this is in
contrast to depletion of other NTC proteins where the
reduced levels of base-paired U4/U6 resulted in increased
levels of free U4 (14). This suggests that CWC2 is required
for maintaining U1, U4 and U5, as well as U6, snRNA
levels. Decreased levels of U4 and U6, in turn, results in a
reduction of the U4/U6 snRNA complex.
Cwc2 interacts directly with snRNAs and different
pre-mRNAs in vitro
As Cwc2 depletion inﬂuences the levels of U1, U4, U5
and U6 snRNAs, it was of interest to determine whether
Cwc2 is associated with any of the snRNAs of the spliceo-
some. Therefore, we expressed and puriﬁed C-terminally
6His-tagged Cwc2 (Cwc2-His) from bacteria (Figure 3A)
to determine if it interacted with snRNAs in vitro.
Incubation of puriﬁed Cwc2-His with U1, U2, U4, U5
or U6 snRNAs and analysis by EMSA indicate that the
Figure 2. Cwc2 is required for cell growth, pre-mRNA splicing, the levels of the U1, U4, U5 and U6 snRNAs and maintenance of the U4/U6
complex. (A) The CWC2 gene was put under control of the GAL1 promoter. Growth over time of the GAL1-CWC2 yeast in the presence of
galactose, which allows expression of Cwc2, or glucose, which represses Cwc2 expression. (B) Primer extension analysis of splicing of the U3 intron-
containing genes U3A and U3B. When CWC2 is switched oﬀ by growth in glucose there is an accumulation of U3 precursor RNA indicating a
defect in pre-mRNA splicing. (C) Depletion of Cwc2 inﬂuences the levels of the U1, U4, U5 and U6 snRNAs. Primer extension analysis of snRNA
levels before and following the switch of the GAL1-CWC2 strain to glucose. The RNA utilized for snRNA primer extension is identical to that used
in (B). (D) Depletion of Cwc2 reduces the levels of U4/U6 complex and free U4 and U6. RNA was isolated under nondenaturing conditions from
the GAL1-CWC2 strain grown in galactose or glucose, hybridized to radiolabeled probes complementary to U4 or U6 and separated on a
9% polyacrylamide gel.
4210 Nucleic Acids Research, 2009, Vol. 37,No. 13Cwc2-His is able to bind to all ﬁve snRNAs (Figure 3B).
However, under the same conditions Cwc2-His did not
bind U3 or U14 snoRNAs, demonstrating some speciﬁcity
for snRNAs (Figure 3B). Titration of the concentration of
Cwc2-His between 1.5mM and 6.5mM followed by analy-
sis of snRNA binding by EMSA reveals that snRNA
binding is variable, with Cwc2-His binding to U4 and U6
occurring at lowest concentrations of the protein followed
by U2, U5 and U1 (Figure 3C). Using a range of lower
concentrations of Cwc2-His revealed that with the U4
and U6 snRNAs, binding is apparent at concentrations
as low as 250 and 1000nm, respectively (Figure 4A).
Cwc2-His, therefore, appears to have the ability to bind
to all the snRNAs in vitro with varying eﬃciency.
As Cwc2-His can bind diﬀerentially to more than one
snRNA, its ability to bind pre-mRNA was also tested by
EMSA. Three diﬀerent intron-containing pre-mRNAs
were tested, ACT1, CYH2 and RPS10B (Figure 4B).
Cwc2-His bound to all three pre-mRNAs in vitro,
although requiring higher concentrations of protein than
the snRNAs. Cwc2-His, therefore, binds both snRNAs
and diﬀerent pre-mRNAs in vitro. During spliceosome
activation, NTC association speciﬁes snRNA/pre-mRNA
interactions (7,8). Thus if Cwc2-RNA binding occurs
within spliceosomes, Cwc2 could be involved in specifying
these RNA/RNA interactions.
Cwc2 associates predominantly with the U2 and U6
snRNAs in assembled spliceosomes
To determine whether any of the snRNA interactions
of Cwc2-His found in vitro occur in assembled snRNPs
or spliceosomes, a yeast strain was constructed where the
chromosomal CWC2 gene was fused to the TAP tag (31).
As a control for snRNA association the U2 snRNP pro-
tein Prp21 was also TAP-tagged. Yeast whole-cell splicing
extract was then produced from these two strains and a
wild-type, untagged, strain. Primer extension of RNA iso-
lated from extracts indicated that each strain contains
equivalent levels of snRNAs (Figure 5A, lanes 1–3).
Cwc2-TAP or Prp21-TAP was then precipitated from
extracts with IgG-coated beads, and the RNA associated
with Cwc2-TAP or Prp21-TAP was extracted from the
beads. The presence of all ﬁve snRNAs was then analyzed
by primer extension. In extract alone no snRNAs were
associated with Cwc2-TAP, whereas Prp21-TAP could
precipitate U2 snRNA (Figure 5A, lanes 4 and 5). This
indicates that Cwc2 does not associate with any of the
snRNAs in yeast whole-cell splicing extracts. This agrees
with similar experiments carried out with Prp19 demon-
strating that it is also not associated with snRNPs in
extracts (32). Next, extracts were incubated under splicing
conditions with an ACT1 pre-mRNA (Ac/Cla) which does
not contain sequences after the branch point so cannot
carry out the ﬁrst step of splicing, but allows spliceosome
assembly and NTC binding (33). Under these conditions
the U2 and U6 snRNAs and a small amount of U5
snRNA associated with Cwc2-TAP, whereas U2 and to
a lesser extent U6, associated with the Prp21-TAP
(Figure 5A, lanes 7 and 8). An ACT1 pre-mRNA with a
30-splice site, ACAC mutation was utilized to accumulate
spliceosomes that have completed the ﬁrst step of splicing
but are blocked for the second step of splicing (8,34).
Figure 3. Binding of Cwc2 to snRNAs in vitro.( A) SDS–PAGE analysis of puriﬁed, His-tagged, Cwc2 (lane 2). Molecular weight markers (lane 1)
are indicated to the left of the panel in KiloDaltons. (B) EMSA using
32P end-labeled RNAs that are indicated below the panel. RNA was incubated
without ( ) and with (+) 4.5mM Cwc2-His, then complexes were resolved on 5% nondenaturing polyacrylamide gels. (C) Increasing concentrations
of Cwc2-His protein were incubated with ﬁxed amounts of the individual snRNAs indicated below the panels. Concentrations of Cwc2-His are
indicated above each panel. Complexes were resolved on 5% nondenaturing polyacrylamide gels.
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ACAC pre-mRNA reveal that after the ﬁrst step of splic-
ing the U2 and U6 snRNAs remain associated with
Cwc2-TAP and U2 snRNA with Prp21-TAP (Figure 5A,
lanes 10 and 11). There is a slight reduction in U6 snRNA
association with the Cwc2-TAP and very little U5 snRNA
association (Figure 5A, lane 10). In each condition tested,
the wild-type untagged extract did not precipitate any
snRNAs (Figure 5A, lanes 6, 9 and 12). This indicates
that the U2 and U6 snRNAs predominantly associate
with Cwc2 in assembled spliceosomes under native
conditions.
Cwc2 contacts U6 snRNA directly in active spliceosomes
As the NTC stabilizes U6 association within active spli-
ceosomes, we next wanted to determine if the Cwc2-U6
association in spliceosomes detected under native condi-
tions reﬂected a direct RNA–protein interaction.
Spliceosomes blocked before the ﬁrst and second steps
of splicing, using the Ac/Cla and ACAC pre-mRNAs,
respectively, were assembled in Cwc2-TAP extract and
UV crosslinked. A biotinylated oligonucleotide comple-
mentary to U6 snRNA was then used to purify U6
snRNA and associated crosslinked proteins using strepta-
vidin-coated magnetic beads under stringent denaturing
conditions. Crosslinking of Cwc2-TAP to U6 snRNA
was then analyzed by immunoblotting with anti-TAP anti-
body. Cwc2-TAP was found to crosslink to U6 snRNA in
both ﬁrst and second step spliceosomes (Figure 5B, top
panel, lanes 1 and 3). Interestingly, direct crosslinking of
Cwc2 to U6 decreased following the ﬁrst step of splicing
similar to that observed under native conditions. Without
UV irradiation this Cwc2–U6 interaction was dissociated
under the selection conditions used (Figure 5B, top panel,
lanes 2 and 4). The requirement for UV for detection
of the Cwc2–U6 interaction demonstrates a direct
RNA–protein interaction in the ﬁrst and second step
spliceosomes. The U2 snRNP protein, Prp11, was not
found to crosslink to U6 snRNA in an identical experi-
ment carried out in Prp11-TAP extract (Figure 5B,
bottom panel). Selection of crosslinked ﬁrst and second
step spliceosomes with biotinylated oligonucleotides com-
plementary to the U2 or U5 snRNAs did not co-purify
any crosslinked Cwc2-TAP, implying that Cwc2 does not
contact these snRNAs directly (Figure 5C). The direct
contact with U6 snRNA suggests that Cwc2 may be
involved in the role of the NTC in anchoring U6 to the
spliceosome after U4 dissociation and specifying its inter-
actions with the pre-mRNA.
Mutation of the Cwc2 zinc finger and RRM destabilize
Cwc2 and inhibit growth in vivo
The presence of a CCCH zinc ﬁnger and an RRM motif in
Cwc2 suggests that one, or both, of these motifs may be
important for Cwc2–RNA binding in pre-mRNA splicing.
Each motif is known to bind RNA although RRMs are
also known to bind protein. To determine whether speciﬁc
amino acids within and around these motifs were impor-
tant for Cwc2 function in vivo a yeast strain was con-
structed (YCWC2KO) in which the CWC2 coding
sequence was deleted and complemented by a CEN
URA3 plasmid containing the wild-type CWC2 gene.
Figure 4. Binding of Cwc2 to the U4 and U6 snRNAs and diﬀerent pre-mRNAs in vitro.( A) EMSA using
32P end-labeled U4 and U6 snRNAs.
Increasing concentrations of Cwc2-His protein were incubated with a ﬁxed amount of a labeled RNA. The identity of the RNA is indicated below
the panels. Concentrations of Cwc2-His are indicated above each panel. Complexes were resolved on 5% nondenaturing polyacrylamide gels. (B)
Binding of Cwc2 to the ACT1, CYH2 and RPS10B pre-mRNAs in vitro. EMSA using
32P end-labeled pre-mRNAs. Increasing concentrations of
Cwc2-His protein were incubated with a ﬁxed amount of a labeled RNA. The identity of the RNA is indicated below the panels. Concentrations of
Cwc2-His are indicated above each panel. Complexes were resolved on 5% nondenaturing polyacrylamide gels.
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expressing either wild-type Cwc2 with three C-terminal
FLAG tags (Cwc2-3FLAG) or Cwc2-3FLAG containing
mutations in Cwc2. Transformants were transferred to
media containing 5-FOA, which selects against the wild-
type CEN URA3 plasmid and tests the ability of CWC2
mutants to support growth of yeast cells as the sole source
of CWC2. RRM motifs contain three aromatic residues
that are important for RNA binding (35). Two of these
aromatic residues are in the RNP1 and the third in the
RNP2 consensus sequences (Figure 1B). Mutation in
the Cwc2 RRM of the conserved residue adjacent to the
RNP2 motif (T136V) and the aromatic residue within
RNP2 (Y138A) supported growth of yeast cells as the
sole source of Cwc2 (Figure 6A). Mutation of one of the
aromatic residues within RNP1 (F183D) also supported
growth of yeast cells (Figure 6A). In contrast, mutation of
the second aromatic residue in RNP1 F186D did not sup-
port growth (Figure 6A). Mutation of a cysteine in the
zinc ﬁnger domain of Cwc2 to a histidine (C87H), which
still has the potential to coordinate zinc, allows yeast
growth (Figure 6B). However, mutation of a cysteine
residue in the zinc ﬁnger to an amino acid that does not
coordinate zinc (C73Y) does not support growth of yeast
cells as the sole source of Cwc2 (Figure 6B). Finally, muta-
tion of two highly conserved amino acids in Cwc2 (Y34A
and W37A) were each able to support growth of yeast
cells (Figure 6B). Expression of the mutant proteins, in
the presence of the CEN URA3 plasmid containing the
wild-type CWC2 gene, was analyzed by immunoblotting
using anti-FLAG antibody (Figure 6C). The two lethal
Cwc2 mutant proteins (F186D and C73Y) were not
stably expressed in vivo (Figure 6C, lanes 3 and 6). The
viable mutant, C87H, was also not stably expressed in vivo
(Figure 6C, lane 7); however, longer exposure revealed
very low levels of the F186D, C73Y and C87H mutant
proteins, with slightly higher levels of C87H maybe
explaining why it produces a viable phenotype (data not
shown). The signiﬁcant reduction in mutant protein
explains the eﬀect these mutations have on viability as
the sole source of Cwc2 protein.
Cwc2 RRM interacts with U1, U2, U4 and U6 but not
U5 snRNA in vitro
Mutagenesis of the RRM and zinc ﬁnger motifs destabi-
lizes Cwc2 in vivo, probably by preventing proper folding
of these domains, consequently we decided to analyze
the RNA binding of these domains in vitro. We attempted
to express and purify from bacteria His-tagged fragments
of Cwc2 containing these two domains individually
for use in in vitro binding assays. We were unable to
express a soluble zinc ﬁnger-containing fragment (data
not shown), but an RRM-containing fragment was
expressed and puriﬁed successfully and used for EMSAs
(Figure 7A). The RRM fragment interacts with the U1,
U2, U4 and U6 snRNAs in vitro but did not appear to
Figure 5. Cwc2 is only snRNA-associated within spliceosomes and con-
tacts the U6 snRNA directly in ﬁrst and second step spliceosomes. (A)
Yeast whole-cell extract was made from yeast strains containing TAP-
tagged Cwc2 (Cwc2-TAP), TAP-tagged Prp21 (Prp21-TAP) or a non-
TAP-tagged wild-type (WT) strain. Total RNA was isolated from
1.25% of extract used in the precipitations from extracts and splicing
reactions, then subjected to primer extension with primers complemen-
tary to the U1, U2, U4, U5 and U6 snRNAs (lanes 1–3, Input). Extract
alone (lanes 4–6, Extract), extract incubated under splicing conditions
with an ACT1 pre-mRNA truncated after the branchpoint sequence
(lanes 7–9, Ac/Cla) or extract incubated under splicing conditions
with an ACT1 pre-mRNA with a 30-splice site mutation (lanes 10–12,
ACAC) were precipitated with IgG-coated beads. RNA extracted from
the beads was subjected to primer extension with primers complemen-
tary to the U1, U2, U4, U5 and U6 snRNAs. The positions of each
snRNA are shown on the left. (B) Yeast whole-cell extract was made
from yeast strains containing TAP-tagged Cwc2 (Cwc2-TAP) (top
panel) and TAP-tagged Prp11 (Prp11-TAP) (bottom panel). Splicing
reactions with Ac/Cla (lanes 1 and 2) or ACAC (lanes 3 and 4) pre-
mRNA were UV irradiated (lanes 1 and 3) before selection with a
biotinylated oligonucleotide complementary to U6 snRNA, under
denaturing conditions. Cwc2-TAP or Prp11-TAP were detected with
the anti-TAP antibody by immunoblotting. As a control, identical spli-
cing reactions were subjected to selection of U6 under the same dena-
turing conditions without previous UV irradiation (lanes 2 and 4). Lane
5 shows 1% of the TAP-tagged extract used in splicing reactions. (C)
As in (B) except selection from Cwc2-TAP extract splicing reactions
after crosslinking utilized biotinylated oligonucleotides complementary
to U2 snRNA (top panel) or U5 snRNA (bottom panel).
Nucleic Acids Research, 2009,Vol.37, No. 13 4213interact with the U5 snRNA (Figure 7B). Like full-length
Cwc2, the RRM fragment did not interact with the U3 or
U14 snoRNAs (Figure 7B). Titration of the concentration
of the RRM fragment revealed that it interacted with U1
and U6 more eﬃciently, and with U4 snRNA less eﬃ-
ciently, than the full-length Cwc2 (data not shown).
The Cwc2 RRM may, therefore, be responsible for the
binding of U6 snRNA in spliceosomes. The rest of the
protein also appears to have a role in binding some
RNAs, especially U5.
DISCUSSION
The NTC plays an important role in the catalytic activa-
tion of the spliceosome. The NTC is known to promote
the stable association of the U5 and U6 snRNAs with the
spliceosome (7,8). To determine how the NTC associates
with the snRNAs of the spliceosome, we have investigated
the RNA interactions of Cwc2, the only putative RNA
binding protein of the NTC. Here, we demonstrate that
Cwc2 has the ability to bind all ﬁve snRNAs in vitro. Cwc2
can also bind three diﬀerent pre-mRNAs in vitro, although
with less eﬃciency than snRNA binding. Binding to U4,
followed by U6, occurred most eﬃciently at the lowest
concentrations of Cwc2, however, in assembled spliceo-
somes we ﬁnd that Cwc2 interacts predominantly with
U2 and U6 snRNAs and crosslinks directly to the U6
snRNA. Finally, Cwc2 depletion appears to have a more
dramatic eﬀect on snRNA levels than other NTC proteins,
reducing the levels of U1, U4 and U5 as well as U6.
Taken together, we propose that Cwc2 functionally links
the NTC with the pre-mRNA and snRNAs of the
spliceosome.
It has been shown that deletion or depletion of NTC
proteins results in decreased U4/U6 stability/biogenesis as
a result of inhibition of spliceosome recycling (14).
Depletion of the essential NTC proteins Prp19, Ntc90
and Ntc77 or deletion of the nonessential Ntc25 and
Ntc25/Ntc30 all resulted in decreased levels of U6
snRNA leading to reduced levels of the U4/U6 complex,
and in turn increased levels of free U4 snRNA (14). It was
proposed that free U4 accumulation is a general property
of NTC protein depletion or deletion. We have found that
depletion of Cwc2 also results in a decrease in U6 snRNA
levels and reduced levels of the U4/U6 complex as
observed with depletion or deletion of other NTC pro-
teins. However, depletion of Cwc2 also results in reduced
levels of U1, U5 and, to a lesser extent, U4 snRNA. There
was also a reduction in free U4 snRNA despite the
reduced levels of the U4/U6 complex. This reduction
in snRNA levels occurs after 8h of Cwc2 depletion and
corresponds to a strong block in pre-mRNA splicing.
Depletion of Cwc2 appears to exhibit more dramatic
eﬀects on the snRNAs than depletion of other NTC pro-
teins. It will be interesting to determine exactly how Cwc2
depletion downregulates snRNAs and the relationship this
has to snRNP biogenesis.
Figure 6. Mutations in the Cwc2 zinc ﬁnger and RRM are lethal in vivo
due to reduced expression of the mutant protein. A haploid yeast strain
with the chromosomal CWC2 gene knocked-out and CWC2 on a
URA3 marked plasmid (pRS416-Cwc2) was created. This strain was
transformed with either a HIS3 marked plasmid alone (pRS413) or
pRS413 with wild-type Cwc2 with three C-terminal FLAG tags
(Cwc2-3FLAG) or Cwc2-3FLAG with the indicated Cwc2 mutations
in the RRM domain (A) or mutations of conserved N-terminal residues
including the zinc ﬁnger domain (B). Single colonies from these trans-
formations were streaked onto 5-FOA to select against the wild-type
pRS416-Cwc2 plasmid. The plates were photographed after incubation
at 308C for 3 days. (C) Immunoblot with the anti-FLAG antibody and
the G6PDH antibody (against Zwf1 protein, as a loading control) of
extracts from strains containing the pRS416-Cwc2 wild-type plasmid
and the pRS413-Cwc2-3FLAG wild-type or mutant plasmid.
Figure 7. Binding of Cwc2 RRM fragment to snRNAs in vitro.
(A) SDS–PAGE analysis of puriﬁed, His-tagged, Cwc2 RRM frag-
ment (lane 2). Molecular weight markers (lane 1) are indicated to the
left of the panel in KiloDaltons. (B) EMSA using
32P end-labeled
RNAs. The identity of the RNA is indicated below the panel. RNA
was incubated without ( ) and with (+) 4.5mM Cwc2-His RRM frag-
ment, then complexes were resolved on 5% nondenaturing polyacryla-
mide gels.
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by its ability to bind all ﬁve snRNAs and three diﬀerent
pre-mRNAs in vitro. This suggests that Cwc2 binds RNA
nonspeciﬁcally; however, it does not bind the U3 or U14
snoRNAs under similar conditions. The binding assays
were carried out in the presence of excess unlabeled
tRNA. In the absence of excess tRNA, Cwc2 can bind
the U3 and U4 snoRNAs in vitro (data not shown), there-
fore, it appears that Cwc2 has general RNA binding
properties but with higher speciﬁcity for snRNAs and
pre-mRNAs. There may be a common structural or
sequence element within the snRNAs that is recognized
by Cwc2 that is not present within U3 or U14
snoRNAs. Full-length Cwc2 bound to U4, followed by
U6, most eﬃciently at the lowest concentrations of
Cwc2. A fragment of Cwc2 containing the RRM was
able to bind all the snRNAs except U5. Like full-length
Cwc2, the Cwc2 RRM did not bind the U3 or U14
snoRNAs under the conditions used. The RRM fragment
of Cwc2 is, therefore, likely to be involved in the RNA
binding activity but the rest of the protein must have an
important role, especially in U5 binding in vitro. Cwc2
may be able to contact more than one snRNA at once
through its two diﬀerent motifs. Lethal mutations in the
RRM and zinc ﬁnger aﬀected expression of the protein,
probably by causing incorrect folding of these domains.
Further mutagenesis is required to assess the function of
these domains in vivo.
The NTC has previously been shown to join the spliceo-
some after the dissociation of U1 and U4 (36). Prp19 was
not found to be associated with the U4 containing spliceo-
some even in low ATP conditions, which inhibits U4 dis-
sociation. Our immunoprecitation experiments agree
with this timing, demonstrating that Cwc2 interacts with
active spliceosomes containing U2, U6 and U5. Thus,
even though Cwc2 can bind U1 and U4 by EMSA, it
appears not to contact these snRNAs in snRNPs or in
assembled spliceosomes. This is intriguing considering
puriﬁed Cwc2 binds U4 with greatest eﬃciency at concen-
trations as low as 250nM. However, before performing
the immunoprecipitation, extracts were allowed to accu-
mulate spliceosomes blocked just prior to the ﬁrst step or
after the ﬁrst step of splicing, after U1 and U4 dissocia-
tion. Cwc2 immunoprecipitations contained a very small
amount of U4 when spliceosomes were blocked earlier in
assembly with low ATP concentrations (data not shown).
Therefore, it is possible that Cwc2 does contact U4 and
U1 in splicing extracts earlier in spliceosome assembly.
Alternatively, while Cwc2 can bind all the snRNAs
in vitro, Cwc2 RNA binding may be speciﬁed or regulated
in splicing extracts by other components of the NTC/
spliceosome.
Possible candidates for regulating the RNA binding
activity of Cwc2 are Prp19 and Ntc30. Both Prp19 and
Ntc30 interact with Cwc2 in the yeast two-hybrid assay
(9). In addition, Prp19 interacts with Cwc2 directly in vitro
(9). These protein–protein interactions could regulate the
RNA binding ability of Cwc2 within the NTC. As Prp19 is
in the U-box family of E3 ubiquitin ligases (37), and
can interact directly with Cwc2 in vitro, Prp19 may also
target Cwc2 for ubiquitination. Ubiquitination can result
in a number of diﬀerent consequences for a protein.
For example, ubiquitination can inﬂuence the stability,
conformation, activity or localization of a protein (38).
Prp19 has been demonstrated to have ubiquitin ligase
activity in vitro and interacts with subunits of the proteo-
some (39,40). However, no substrates for the ubiquitin
ligase activity of Prp19 are known. An attractive hypoth-
esis is that Cwc2 is the target for the Prp19 ubiquitin ligase
activity and that ubiquitination of Cwc2 may regulate
its RNA binding activity in the NTC. If Cwc2 RNA bind-
ing is regulated by components of the NTC, by protein–
protein interactions or modiﬁcation, Cwc2 would not be
able to bind snRNAs in splicing extracts until the correct
time in spliceosome assembly.
Cwc2 was found to contact the U6 snRNA directly in
spliceosomes blocked both prior to the ﬁrst and second
steps of splicing. It has been demonstrated previously that
the NTC is required for stable association of the U5 and
U6 snRNAs with the active spliceosome and for specifying
their interactions with the pre-mRNA before the ﬁrst
step of splicing (7,8). In order for this function to be
carried out, it is expected that component(s) of the NTC
will contact these snRNAs directly within spliceosomes.
Until now, however, no proteins of the NTC have been
demonstrated to be able to bind RNA. The fact that Cwc2
directly contacts U6 snRNA within spliceosomes suggests
that it functions in this role of the NTC, stabilizing U6
snRNA association with the spliceosome. The NTC was
found to specify the U6 interaction at the 50-splice site and
to bring about Lsm dissociation from the 30-end of U6
enabling it to interact with the pre-mRNA intron (7,8).
It will be interesting in the future to map the Cwc2 cross-
link within the U6 snRNA to see if it is involved with one
or both of these interactions.
The NTC remains associated with the spliceosome
during the two catalytic steps of splicing. Cwc2 was also
found to crosslink to U6 snRNA in spliceosomes blocked
after the ﬁrst but before the second step of splicing.
Therefore, the NTC may be important for specifying U6
snRNA interactions at this stage, for example, during the
proposed disruption of the U6-50-splice site interaction
(41). There appears to be a reduction in U6-Cwc2 associ-
ation in both the crosslinking and immunoprecipitation
experiments. This apparent reduction may represent
remodeling of the Cwc2-U6 interaction, allowing U6 to
form speciﬁc interactions required for the second step of
splicing.
Although Cwc2 can interact with U2 and U5 in vitro
and associates with active spliceosomes containing these
snRNAs, we were not able to detect any crosslinks
between Cwc2 and U2 or U5. This is intriguing as the
NTC also stabilizes U5 association with the spliceosome
(7,8). It may be that crosslinks were not selected by our
method, although the U2 and U5 biotin oligonucleotides
were able to hybridize to these snRNAs by native gel
electrophoresis (data not shown). Alternatively, another
protein of the NTC may bind U5 snRNA in spliceosomes.
The ability of Cwc2 to bind to U6 snRNA in the spliceo-
some suggests that it may, at least in part, form the link
between the NTC and the RNAs of the spliceosome.
Nucleic Acids Research, 2009,Vol.37, No. 13 4215This link would allow the NTC to regulate important
RNA/RNA dynamics during pre-mRNA splicing.
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